openPR Logo
Press release

Drug-induced Nephrotoxicity Treatment Market Value Projected to Expand during 2022-2032 | Aushon BioSystem Inc., Epistem Ltd G.E., Healthcare Inc.

01-24-2022 02:38 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

The market report by Fact.MR envelopes an all-in information of the global Drug-induced Nephrotoxicity Treatment market and the nature of the market growth over the foreseeable period.

The report provides a comprehensive elaboration of the positives and negatives of the global Drug-induced Nephrotoxicity Treatment market with DROT and Porter’s Five Forces analysis.

To Get In-depth Information View Full Report - https://www.factmr.com/report/1525/druginduced-nephrotoxicity-treatment-market

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Drug-induced Nephrotoxicity Treatment.

The Market Survey examines the Global Drug-induced Nephrotoxicity Treatment Sales for the forecast period 2022- 2031. The report examines the Drug-induced Nephrotoxicity Treatment market key trends, growth opportunities and Drug-induced Nephrotoxicity Treatment market size.

To Get In-depth Insights Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1525

Drug-induced Nephrotoxicity Treatment Market: Segmentation

Tentatively, the global drug-induced nephrotoxicity treatment market can be segmented on the basis of biomarker and end users, and geography.

Based on biomarkers, the global drug-induced nephrotoxicity treatment market is segmented as:

Immunoglobulin G
Albumin
Microglobulins
Cystatin C Retinol binding protein
Cytokines
Interferons
Interleukins
N-Acetyl-D-Glucosaminidase
Clusterin
Osteopontin
Kidney Injury Molecule-1 (KIM-1)
Neutrophil gelatinase-associated lipocalin (NGAL)

Based on end users, the global drug-induced nephrotoxicity treatment market is segmented as:

Pharmaceutical and Biotechnology Companies
Academic Institutes
Research Organizations
Others

Key questions answered in Drug-induced Nephrotoxicity Treatment Market Survey Report:

1) What is the current scenario and key trends in Drug-induced Nephrotoxicity Treatment Market?
2) What are the key strategies companies are adopting to increase their consumer base?
3) What are the key categories within the Drug-induced Nephrotoxicity Treatment segments and their future potential?
4) What is the Drug-induced Nephrotoxicity Treatment Market size and what are the opportunities for the key players?
5) What are the major Drug-induced Nephrotoxicity Treatment Market drivers and their expected impact during the short, medium, and long terms?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1525

Drug-induced Nephrotoxicity Treatment Market: Key Players

Examples of some of the key players operating in the global drug-induced nephrotoxicity treatment market are

Roche Diagnostic Limited
Siemens Healthcare
Abbott Laboratories Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Aushon BioSystem Inc.
Epistem Ltd
G.E. Healthcare Inc.
Affymetrix Inc.

Companies are conducting research for the development of new drug-induced nephrotoxicity treatment biomarkers which expected to provide the high growth opportunity for drug-induced nephrotoxicity treatment market.

Essential Takeaways from the Drug-induced Nephrotoxicity Treatment Market Report

i) Comparison of prominent players operating in the Drug-induced Nephrotoxicity Treatment market.
ii) Recent developments and key strategies adopted by market players.
iii) Study of the micro and macro-economic growth indicators.
iv) Impact of the various factors on the value chain of the Drug-induced Nephrotoxicity Treatment market.
v) Growth opportunities for emerging market players in various regional markets.
vi) Current trends influencing the scenario of the Drug-induced Nephrotoxicity Treatment market.

Get Access To TOC Covering 200+ Topics - https://www.factmr.com/connectus/sample?flag=T&rep_id=1525

The Report Covers Exhaustive Analysis On:

1) Drug-induced Nephrotoxicity Treatment Market Drivers, Segments and Restraints.
2) Drug-induced Nephrotoxicity Treatment Market Survey and Dynamics
3) Drug-induced Nephrotoxicity Treatment Market Size & Demand
4) Drug-induced Nephrotoxicity Treatment Key Trends/Issues/Challenges
5) Drug-induced Nephrotoxicity Treatment Sales, Competition & Companies involved

Read More Trending and Similar Reports from Fact.MR – https://www.einpresswire.com/article/557146132/asia-to-account-for-40-of-the-market-share-of-nano-lubricants-over-the-forecast-period

Contact
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website - https://www.factmr.com/
Research Insight - https://www.factmr.com/report/1525/druginduced-nephrotoxicity-treatment-market

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug-induced Nephrotoxicity Treatment Market Value Projected to Expand during 2022-2032 | Aushon BioSystem Inc., Epistem Ltd G.E., Healthcare Inc. here

News-ID: 2536582 • Views:

More Releases from Fact.MR

Comprehensive Analysis of the Nickel Mining Market: Technology Evolution, Regional Demand & Forecast Scenarios to 2036
Comprehensive Analysis of the Nickel Mining Market: Technology Evolution, Region …
The global nickel mining market is entering a pivotal decade as demand dynamics shift from traditional stainless-steel end uses toward a rapidly growing appetite from battery manufacturers supporting electric vehicles (EVs) and energy storage. Nickel's role as a high-energy-density battery metal-especially in nickel-rich chemistries used for cathodes-combined with steady demand for stainless steel, means miners and refiners face both opportunity and pressure to scale sustainable, cost-efficient production while managing environmental
12-18-2025 | Health & Medicine
Fact.MR
Molecular Diagnostics For STD Market Deep-Dive 2026-2036: Strategic Forecasts, M …
The global market for molecular diagnostics targeting sexually transmitted diseases (STDs) is poised for substantial growth through 2035 as healthcare systems prioritize rapid, accurate, and point-of-care testing to curb infection spread and improve patient outcomes. Molecular methods - including nucleic acid amplification tests (NAATs), PCR-based assays, isothermal amplification, and multiplexed platforms - deliver high sensitivity and specificity for pathogens such as chlamydia, gonorrhea, syphilis (molecular assays for Treponema detection), trichomonas,
Medical Adhesives Market Transformation Report 2036: Innovation Trends, Sustainability Drivers & Competitive Positioning
12-18-2025 | Health & Medicine
Fact.MR
Medical Adhesives Market Transformation Report 2036: Innovation Trends, Sustaina …
The global medical adhesives market is poised for steady growth through 2035 as healthcare delivery shifts toward faster, less invasive procedures, increased outpatient care, and expanded use of adhesive-based devices and dressings. Medical adhesives - ranging from cyanoacrylates and polyurethane adhesives to silicone-based adhesives, hydrogels, and bioadhesives - are increasingly used across wound closure, surgical sealing, topical dressings, wearable devices, transdermal drug delivery, and medical device assembly. As technology advances
Lysosomal Storage Disease Treatment Market Valuation, ROI Potential & Long-Term Growth Prospects (2026-2036)
12-18-2025 | Health & Medicine
Fact.MR
Lysosomal Storage Disease Treatment Market Valuation, ROI Potential & Long-Term …
The lysosomal storage disease (LSD) treatment market is entering a dynamic phase of innovation and commercialization as advances in molecular diagnostics, enzyme technologies, and gene therapies broaden therapeutic options for a set of rare, genetically driven disorders. LSDs including Gaucher disease, Fabry disease, Pompe disease, and mucopolysaccharidoses (MPS) collectively affect tens of thousands of patients worldwide. Historically underserved due to small patient populations and complex biology, this therapeutic area is

All 5 Releases


More Releases for Nephrotoxicity

Platinum-Based Chemotherapy and Nephrotoxicity Market Projected to Reach USD 3.9 …
Pune, India, December 2025 - The global Platinum-Based Chemotherapy and Nephrotoxicity Market is expected to grow from an estimated USD 2.2 billion in 2024 to USD 3.9 billion by 2034, exhibiting a CAGR of approximately 6.0% over the forecast period. The market growth is fueled by the widespread use of platinum-based chemotherapeutics, rising incidence of cancer, and increasing demand for nephroprotective strategies to reduce treatment-associated kidney damage. Download Full PDF Sample
Platinum-based Chemotherapy and Nephrotoxicity Market to Reach USD 2.8 Billion b …
Platinum-based chemotherapy-primarily involving cisplatin, carboplatin, and oxaliplatin-remains a cornerstone in the treatment of various solid tumors, including lung, ovarian, testicular, and bladder cancers. These agents are highly effective due to their DNA-damaging mechanisms, but they carry significant risks, notably nephrotoxicity (kidney damage). Nephrotoxicity can manifest as acute kidney injury (AKI) or chronic kidney disease (CKD), often necessitating dose adjustments or discontinuation of therapy, impacting overall treatment outcomes. Download Full PDF Sample
Platin Based Chemotherapies And Nephrotoxicity Therapeutics Market Size in the 7 …
DelveInsight's "Platinum-based Chemotherapy and Nephrotoxicity Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Platinum-based Chemotherapy and Nephrotoxicity, historical and forecasted epidemiology as well as the Platinum-based Chemotherapy and Nephrotoxicity trends in the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan. Discover Key Insights into the Platin based chemotherapies and nephrotoxicity Market with DelveInsight's In-Depth Report @ Platin based chemotherapies
Drug-induced Nephrotoxicity Treatment Market Trends and Forecast Report 2022 | B …
The QY Research released a latest market research report on the global and United States Drug-induced Nephrotoxicity Treatment market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Drug-induced Nephrotoxicity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by
Drug-induced Nephrotoxicity Treatment Market Trends, Regulations And Competitive …
Drug-induced nephrotoxicity or drug-induced kidney disease (DIKD) is primarily recognized as a significant contributor to kidney disease including acute kidney injury (AKI) and chronic kidney disease (CKD). Drug-induced nephrotoxicity is often go unrecognized, particularly in the setting of short drug exposures, which leads challenges in assessing the incidence, severity and long-term consequences of drug-induced kidney disease. The mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation,
Drug-induced Nephrotoxicity Treatment Market: Future Forecast Indicates Impressi …
Drug-induced nephrotoxicity or drug-induced kidney disease (DIKD) is primarily recognized as a significant contributor to kidney disease including acute kidney injury (AKI) and chronic kidney disease (CKD). Drug-induced nephrotoxicity is often go unrecognized, particularly in the setting of short drug exposures, which leads challenges in assessing the incidence, severity and long-term consequences of drug-induced kidney disease. The mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation,